Disease modification in rheumatoid arthritis with leflunomide

Scandinavian Journal of Rheumatology, Supplement

Volumn 28, Issue 112, 1999, Pages 9-14

  Emery, P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Leflunomide; Methotrexate; Radiographic disease progression; Sulfasalazine

Indexed keywords

ANTIRHEUMATIC AGENT; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE; ISOXAZOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; BONE DESTRUCTION; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TIME; TREATMENT OUTCOME; MIDDLE AGED; RADIOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; SULFASALAZINE; TIME FACTORS;

EID: 0033392092     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097499750042236     Document Type: Article

References (33)

1. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91.
2. van leeuven MA, van Rijswijk MH, van der Heijde DMFM, le Meerman GI, van Riel PLCM, Houtman PM, et al. The acute phase response in relation to radiographic progression in early rheumatoid arthritis. Br J Rheumatol 1993:32 Suppl 30:9-13.
3. Donnelly S, Scott DL, Emery P. The long-term outcome and justification for early treatment. Clin Rheumatol 1992;19:1831-4.
4. Emery P, Salmon M. Early rheumatoid arthritis: time to aim for remission? Ann Rheum Dis 1995;54:944-7.
5. Genant HK, Jiang Y, Peterfy C, Lu Y, Redei J, Countryman PJ. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998;41:1583-90.
6. Sharp JT, Lidsky MD, Collins LC, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Arthritis Rheum 1971;14:706-20.
7. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
8. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared to placebo and methotrexate. Arch Int Med 1999;159: in press.
9. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Loew-Friedrich I, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 1999;353:259-66.
10. Forre Ø. Norwegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. Arthritis Rheum 1994;37:1506-12.
11. Hannonen P, Mottonen T, Hakola M, Oka M. Sulfasalazine in early rheumatoid arthritis. Arthritis Rheum 1993;36:1501-9.
12. Boers M, Verhoeven AC, Markusse HM, van de Laar MAF, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
13. Pullar T, Hunter JA, Capell HA. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987;46:398-402.
14. van der Heijde DM, van Riel PL, Gribnau FW, Nuver-Zwart IH, van de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989;1:1036-8.
15. van der Heijde DMFM, san Riel PLCM, Nuver-Zwart IH, van de Putte LBA. Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up (letter) Lancet 1990;335:539.
16. Box SA, Pullar T. Sulphasalazine in the treatment of rheumatoid arthritis. Br J Rheumatol 1997;36:382-6.
17. Kremer JM. Methotrexate and radiographic disease progression in patients with rheumatoid arthritis. J Rheumatol 1999;26:241-3.
18. Drosos AA, Tsifetaki N, Tsiakou EK, Timpanidou M, Tsampoulas C, Tatsis CK, et al. Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study. Clin Exp Rheumatol 1997;15:263-7.
19. Jeurissen MEC, Boerbooms AMT, van de putte LBA, Doesburs WH, Lemmens AM. Influence of methotrexate and azothioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Ann Intern Med 1991;114:999-1004.
20. Alarcón GS, López-Méndez A, Walter J, Boerbooms AMT, Russell AS, Furst DE, et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1873.
21. López-Méndez A, Daniel WW, Reading JC, Ward JR, Alarcón GS. Radiographic assessement of disease progression in rheumatoid arthritis patients enrolled in the Cooperative Systemic Studies of the Rheumatic Diseases program randomized clinical trial of methotrexate. auranofin, or a combination of the two. Arthritis Rheum 1993;36:1364-69.
22. Weinblatt ME, Polisson R, Blotner SD, Sosman JL, Aliabadi P, Baker N, et al. The effects of drug therapy on radiographic progression in rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum 1993;36:613-9.
23. Rau R, Herbom G, Menninger H, Sangha O. Progression in early erosive rheumatoid arthritis: 12 month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998;37:1220-6.
24. Maravic M, Bologna C, Daures J-P, Jorgensen C, Combe B, Sany J. Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol 1999;26:262-7.
25. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:577-84.
26. van der Heijde DMFM, van Riel PLCM. van Leeuwen MA. Van't Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25.
27. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis. A 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
28. Plant MJ, Jones PW, Saklatvala J, Ollier WER, Dawes PT. Patterns of radiological progression in early rheumatoid arthritis: results of an 8-year prospective study. J Rheumatol 1998;25:417-26.
29. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Yan PLJ, et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998;57:350-6.
30. Forslind K, Larsson EM, Johansson A, Svensson B. Detection of joint pathology by magnetic resonance imaging in patients with early rheumatoid arthritis. Br J Rheumatol 1997;36:683-8.
31. Jorgensen C, Cyteval C, Anaya JM, Baron MP, Lamarque JL. Sany J. Sensitivity of magnetic resonance imaging of the wrist in very earls rheumatoid arthritis. Clin Exp Rheumatol 1993;11:163-8.
32. Reece RJ, Kraan MC, Radjenovic A, Famell J, O'Connor PJ, Gibbon WW, et al. An explorative study of the change in dynamic MRI-assessed synovial characteristics in patients with rheumatoid arthritis treated with leflunomide or methotrexate. Presented at the XIV EULAR Congress 1999: Abstract no. 110.
33. Reece RJ, Kraan MC, Radjenovic A, Farnell J, O'Connor PJ, Gibbon WW, et al. Dynamic gadolinium-enhanced MRI monitoring of inflammatory changes in rheumatoid arthritis with the new DMARD, leflunomide versus methotrexate. Arthritis Rheum 1999:42 Suppl 9:S131.